Training for anti-COVID-19 health intervention in Villa Clara: a need for health personnel

Authors

Keywords:

coronavirus infections, training courses, professional training, education, medical

Abstract

Background: the availability of Cuban vaccine candidates in the fight against COVID-19 made it possible to carry out health interventions in risk groups and territories. In order to guarantee that the rights, safety and well-being of patients are protected, compliance with the standards of Good Clinical Practices is required by the health professionals involved, hence the prior training of these personnel.
Objective: to describe the training process developed in Villa Clara aimed at health personnel involved in the health intervention with the vaccine candidate Abdala.
Methods: a qualitative research was carried out from April to May 2021 in Villa Clara. Theoretical, empirical, mathematical-statistical methods and the criteria of specialists were used. The basic elements of the training process were identified and evaluation scales were established: successful, moderately successful and not successful.
Results: 87 facilitators were trained through a national workshop on Good Clinical Practices to develop a cascade training. 32 workshops were held that allowed training 99.12% of the planned personnel, who worked during the health intervention in 47 clinical sites. During the previous tours it was verified that 100% of the personnel involved in the intervention had received the workshop given. When evaluating the requirements established for the premises of the site, it was determined that more than 90% were met in all of them.
Conclusions: the training in Good Clinical Practices of the personnel involved in the anti-COVID-19 health intervention in Villa Clara was considered successful.

Downloads

Download data is not yet available.

Author Biographies

Liset Jaramillo Hernández, National Coordinating Center for Clinical Trials

CENCEC. Department of Control and Attention to the National Network of Clinical Trials. Provincial Coordinator of Clinical Trials

Migdalia Rodríguez Rivas, National Coordinating Center for Clinical Trials.

Doctor in medicine. Second degree specialist in Pharmacology. Master in Bioenergetic and Natural Medicine. Assistant Professor. Associate Researcher. Department of Control and Attention to the National Network of Clinical Trials.

Rayza Méndez Triana, National Coordinating Center for Clinical Trials.

Graduate in Pharmaceutical Sciences, Master in General Biochemistry. Assistant Professor. Assistant Researcher. Department of Control and Attention to the National Network of Clinical Trials.

Rayza Marrero Toledo, National Coordinating Center for Clinical Trials.

Graduate in Pharmaceutical Sciences. Master in Public Health. Assistant teacher. Associate Researcher. Department of Control and Attention to the National Network of Clinical Trials.

References

1. Pérez Abreu MR, Gómez Tejeda JJ, Diéguez Guach RA. Características clínico-epidemiológicas de la COVID-19. Rev Haban Cienc Med [Internet]. 2020 [citado 30/07/2021];19(2):[aprox. 18 p.]. Disponible en: http://www.revhabanera.sld.cu/index.php/rhab/article/view/3254

2. Espinosa Ferro Y, Mesa Trujillo D, Díaz Castro Y, Caraballo García L, Mesa Landín MA. Estudio del impacto psicológico de la COVID-19 en estudiantes de Ciencias Médicas, Los Palacios. Rev Cub Salud Pública [Internet]. 2020 [citado 30/07/2021];46(supl. especial):[aprox. 15 p.]. Disponible en: http://scielo.sld.cu/pdf/rcsp/v46s1/1561-3127-rcsp-46-s1-e2659.pdf

3. Llover MN, Jiménez MC. Estado actual de los tratamientos para la COVID-19. FMC [Internet]. 2021 [citado 30/07/2021];28(1):[aprox. 16 p.]. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7826050/pdf/main.pdf

4. Moneriz C, Castro Salguedo C. Promising and potential drugs for the treatment of COVID-19. Rev Chil Infectol [Internet]. 2020 [citado 31/07/2021];37(3):[aprox. 10 p.]. Disponible en: https://scielo.conicyt.cl/pdf/rci/v37n3/0716-1018-rci-37-03-0205.pdf

5. Sedano Chiroque FL, Rojas Miliano C, Vela Ruiz JM. COVID-19 desde la perspectiva de la prevención primaria. Rev Fac Med Hum [Internet]. 2020 [citado 30/07/2021];20(3):[aprox. 8 p.]. Disponible en: http://www.scielo.org.pe/pdf/rfmh/v20n3/2308-0531-rfmh-20-03-494.pdf

6. Ramírez JA. Vacunas para COVID-19. Respirar [Internet]. 2020 [citado 05/08/2021];12(1):[aprox. 2 p.]. Disponible en: https://alatorax.org/es/publicaciones/respirar/32/55 /download/55_file_es_7QkOGB_respirar13-1-editorial.pdf

7. Aguilar Guerra TL, Conner Gorry MA. COVID-19: Requires Innovation, Regulation and Rigor. MEDICC Review [Internet]. 2021 [citado 08/08/2021];23(2):[aprox. 2 p.]. Disponible en: https://mediccreview.org/wp-content/uploads/2021/04/MRApril2021-int-amaylid-arteaga.pdf

8. Vela Valdés J. ¿Qué significan los cinco candidatos vacunales cubanos contra la COVID-19? Rev Cuba Sal Publica [Internet]. 2021 [citado 05/08/2021];47(2):[aprox. 8 p.]. Disponible en: http://www.revsaludpublica.sld.cu/index.php/spu/article/viewFile/3122/1690

9. Vera Carrasco O. Guías de Atención, Guías de Práctica Clínica, Normas y Protocolos de Atención. Rev Med La Paz [Internet]. 2019 [citado 05/08/2021];25(2):[aprox. 8 p.]. Disponible en: http://www.scielo.org.bo/scielo.php?script=sci_arttext&pid=S1726-89582019000200011&lng=es

10. Minsap. Buenas Prácticas Clínicas en Cuba. La Habana: CECMED; 2000. Disponible en: http://www.cecmed.cu/reglamentacion/aprobadas/resolucion-minsap-165-0.

11. Álvarez Guerra S, Rodríguez Alvarez J, Saborido Martín L, González Hernández Z, Riquelme Abreu I. Como asegurar la calidad de los ensayos clínicos en etapa de pandemia. Invest Medico Quirurg [Internet]. 2021 [citado 0/08/2021];13(3):[aprox. 14 p.]. Disponible en: http://www.revcimeq.sld.cu/index.php/imq/article/view/738

12. Arboláez Estrada M, Marrero Toledo R, Méndez Triana R, Rodríguez Rivas M. Eficacia de un curso sobre Buenas Prácticas Clínicas para investigadores vinculados a los ensayos clínicos. EDUMECENTRO [Internet]. 2018 [citado 08/08/2021];10(2):[aprox. 15 p.]. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S2077-28742018000200010&lng=es

13. Hernández Ramírez A, Guevara de León T, Hernández González M, Botello Ramírez E, González Capdevila O. La educación médica posgraduada en el enfrentamiento a la COVID-19 en Villa Clara, Cuba. EDUMECENTRO [Internet]. 2021 [citado 24/05/2021];13(3):[aprox. 15 p.]. Disponible en: http://www.revedumecentro.sld.cu/index.php/edumc/article/view/1997

14. Marañón Cardonne T, Griñan Semanat DY, Landazuri Llago S, Marañón Reyes EJ. Investigaciones clínicas sobre COVID-19. Una breve panorámica. [Internet]. 2020 [citado 12/09/2021];10(3):[aprox.13 p.]. Disponible en: http://revistaccuba.sld.cu/index.php/revacc/article/view/910

15. Candelaria Brito JC, Díaz Cruz SA, Acosta Pérez DM, Labrador Mazón O, Rodríguez Méndez A. Estrategia intervencionista dirigida a la prevención y control de la COVID-19 en Consolación del Sur. Rev Ciencias Médicas de Pinar del Río [Internet]. 2020 [citado 12/09/2021];24(3):e4495. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1561-31942020000300007&lng=es

16. Soldevilla P, Palma D, Hernández A, Rius C. Vacuna antiCOVID-19. La otra cara del espejo: la opinión de 5 expertos en vacunas frente a la actitud de los negacionistas y de los antivacunas. Enf Emerg [Internet]. 2021 [citado 12 /09/2021];20(1):[aprox. 4 p.]. Disponible en: http://enfermedadesemergentes.com/articulos/a769/Articulo%20especial_Dr-Palma.pdf

17. CECMED. Autorización para el Uso de Emergencia de la vacuna ABDALA. Resolución 113/2021. Ámbito Regulador 00-401. La Habana: CECMED; 2021.

Published

2023-05-22

How to Cite

1.
Jaramillo Hernández L, Rodríguez Rivas M, Méndez Triana R, Marrero Toledo R. Training for anti-COVID-19 health intervention in Villa Clara: a need for health personnel. EDUMEC [Internet]. 2023 May 22 [cited 2025 Jun. 30];15(1):e2463. Available from: https://revedumecentro.sld.cu/index.php/edumc/article/view/e2463

Issue

Section

ARTÍCULO ORIGINAL